Excitatory ionotropic and metabotropic glutamate receptors are found throughout the animal kingdom, but inhibitory ionotropic glutamate receptors seem to be confined to invertebrates (reviewed in [l]). Molecular studies on all invertebrate receptors have lagged far behind those of their mammalian counterparts, but recently interest in the glutamate-gated C1-channels (Glu-Cl) has been greatly stimulated by the discovery that, at least in Caenorhabditis elegans, these molecules act as the receptor for, and probable site of action of, the avermectins, a family of potent anthelminthics, insecticides and acaricides. Electrophysiological studies on Xenopus oocytes injected with total C. elegans mRNA showed that ivermectin (22,23-dihydroavermectin B 1) was able to potentiate glutamate-induced C1-currents at nanomolar concentrations [Z], and allowed the expression cloning of two cDNAs encoding subunits of the receptor [3], designated Glu-Cl a (now referred to as a l ) and Glu-Cl P: we also cloned the P-subunit using reverse transcriptase PCR techniques [4] . The sequences of these subunits revealed that the general structure of this receptor is identical with the mammalian y-aminobutyric acid type A (GABA,) and glycine receptors, with a long N-terminal extracellular region and four putative transmembrane domains. No similarity to the mammalian excitatory glutamate receptor sequences was detected. When expressed in Xenopus oocytes, the a 1-subunit forms ivermectin-gated C1-channels, the P-subunit forms Glu-Cl and, on co-expression, an ivermectinpotentiated Glu-C1 is formed [3] . Later experiments demonstrated that the a 1-subunit also possessed a glutamate-binding site, but that binding was not coupled to the opening of the C1-channel [S]. These results are consistent with physiological and pharmacological data that suggest that the inhibitory glutamate receptors most closely resemble GABA, receptors. With the exception of ibotenic acid, glutamatergic agonists generally have no effect at this site, although they are picrotoxin-sensitive [2, 3, 6] .
Xenopus oocytes, the a 1-subunit forms ivermectin-gated C1-channels, the P-subunit forms Glu-Cl and, on co-expression, an ivermectinpotentiated Glu-C1 is formed [3] . Later experiments demonstrated that the a 1-subunit also possessed a glutamate-binding site, but that binding was not coupled to the opening of the C1-channel [S] . These results are consistent with physiological and pharmacological data that suggest that the inhibitory glutamate receptors most closely resemble GABA, receptors. With the exception of ibotenic acid, glutamatergic agonists generally have no effect at this site, although they are picrotoxin-sensitive [2, 3, 6] .
More recently J. Dent and L. Avery communication) have isolated an a2-subunit cDNA from C. elegans; this subunit forms a channel that responds to both glutamate and ivermectin. The a2-subunit gene shows alternative splicing to produce two variants, a long form which has an extended N-terminal extracellular domain and a shorter form which is of similar size to the other subunits. We have isolated a cDNA encoding the P-subunit of the inhibitory glutamate receptor from the parasitic nematode Haemonchus contortus (N. S. Delany, D. L.
Laughton and A. J. Wolstenholme, unpublished work), and Cully et al. [7] have cloned a subunit of the Drosophila receptor: this insect subunit is also capable of responding to both ivermectin and glutamate.
A sequence alignment of the inhibitory glutamate receptor subunits cloned to date is shown in Figure 1 . The shorter form of the C. elegans a2-subunit is shown, the long N-terminal extension shows no sequence similarity to any other receptor subunit. The sequence of a novel subunit cloned in our laboratory, Cegbr3, is included since it is most closely related to the Glu-Cl a-subunits, although as yet we have no functional data to confirm that it is a component of an inhibitory glutamate receptor. All the subunits have the sequence motifs expected of a ligand-gated ion channel, including a highly conserved TM2 region and an extracellular 'Cys loop'. Smith and Olsen [8] reviewed studies identifying specific amino acids essential for agonist and modulator binding in the related GABA, receptors; these are indicated in normal type above the alignment. The GABA-binding site is thought to be formed by the interface between adjacent subunits and so some of these conserved agonist-binding-site residues are found on different subunit subtypes; however, the majority of the Glu-Cl subunits studied to date appear to be capable of binding agonist when expressed as a homomer, and so it seems justified to include all the implicated amino acid residues on the Figure. that the Glu-Cl forms a rather small component of these. The sequences from Figure 1 that do not form ivermectin-gated receptors are those of the P-subunits, but whether this is due to the absence of an ivermectin-binding site is unclear. The only difference between their agonist-binding sites and those of the a-subunits is the histidine residue at position 223 instead of an aromatic amino acid. Although there are a number of other sequence differences between the a-and P-subunits, it is not obvious which of these may prevent ivermectin binding or gating. All of the Glu-Cl sequences obtained to date possess the second pair of extracellular cysteine residues in the extracellular domain (residues 272 and 283 in Figure 1 ) that distinguishes this family of receptors and the vertebrate glycine receptors from the GABAA family.
Nematodes in general, and C. elegans in particular, have many advantages as organisms for studying basic neuroscience. The nervous systems are anatomically simple and well mapped, yet they show a neurochemical complexity comparable with mammals. The genomesequencing project has revealed that C. elegans encodes more than 50 ligand-gated ion channel subunits, and a similar number of neuropeptides have been isolated from nematodes [16] . In addition, superb molecular genetic tools exist for C. elegans, which can be exploited to gain important insights into the role of specific receptors within the whole organism. We have carried out reporter gene studies where the bacterial P-galactosidase gene was fused to 5' flanking sequences from the C. eleguns Glu-Cl P-subunit [17] . The results show that this subunit is expressed on pharyngeal muscle cells: it is known that this muscle is markedly sensitive to inhibition by ivermectin and analogous in both C. elegans and Ascaris suum [18, 19] . The function of Glu-Cl P (presumably in combination with an ivermectin-sensitive a-subunit) is therefore likely to be in the control of pharyngeal pumping, the process by which this organism feeds. The Glu-Cl &sub-unit is a product of the avr-15 gene (J. Dent and L. Avery, personal communication), which is partly responsible for synthetic high-level resistance to ivermectin [ZO] . Glu-Cl receptors are thus a likely target of ivermectin and other avermectins in vivo. The implication is that ivermectin kills worms by preventing feeding and thus causing arrested development and starvation, although whether this is true for parasitic species is open to question. In particular, it is not clear how such a mechanism could rapidly clear adult parasites, which have ample supplies of storage carbohydrates, from a treated host. Ivermectin could kill worms via the interruption of other vital functions carried out by the pharynx, perhaps the regulation of internal pressure [21, 22] , which allows them to maintain shape against external forces and also provides the tension against which the muscles act during movement.
Genomic sequencing and cDNA cloning from C. elegans have revealed that this organism encodes a very large number of ligand-gated C1-channel subunits and some of these are closely related in sequence to the glutamate receptor subunits. One such gene encodes a pair of alternatively spliced subunits (Cegbr2 and Cegbr3) with common N-terminal extracellular domains, but different C-terminal channel domains (D. L. Laughton, G. G. Lunt and A. J.
Wolstenholme, unpublished work). The gene directs the synthesis of two mRNA species, a full-length mRNA of 2150 nt which encodes the Cegbr2 subunit and which contains the Cegbr3 channel-encoding sequence within its 3' untranslated region, and a further spliced mRNA of 1250 nt which encodes the Cegbr3 subunit and from which 657 nt encoding the Cegbr2 channel has been removed. The amino acid sequences of these two subunits are given in Figure 2 . The use of alternative splicing increases the number of subunits and subunit combinations available to the nematode and underlines the neurochemical complexity of this anatomically simple nervous system. Although some subunits of the mammalian receptors, such as the yZ-subunit of the GABAA receptor, are alternatively spliced [23, 24] , and this determines sensitivity to drugs such as ethanol [25] , the pattern is nowhere near as extensive as that observed in C. elegans and other nematodes. In the case of Cegbr2/3, the two subunits should possess identical ligand-binding sites linked to slightly different C1-channels, and the differences between the two channels may contribute
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to our understanding of the structural basis of their properties. In particular, the channel-lining TM2 domains are identical except for two residues, a threonine to serine substitution at position 286 and a serine to alanine switch at position 299 (Figure 2 b ) . The change seen at position 286 is interesting in that mutations at this position in the TM2 domain of insect GABA receptors cause dieldrin-and picrotoxin-resistance [26] , this amino acid has been identified on the lumen of the channel of mammalian GABA, receptors [27] and mutations at this position alter the ability of the C. eleguns Glu-Cl a-subunit to respond to applied glutamate [5] . At present, we have no information on whether these two subunits are part of distinct receptor subtrpes expressed on different cells, or whether they co-assemble into the same receptor. When functional data are obtained these subunits should allow us to probe the molecular basis of any differences in channel properties that are detected; it would be surprising if the worm went to so much trouble to produce two subunits with identical biophysical properties. Qualitative reverse transcriptase PCR experiments on synchronous cultures have shown that both mRNAs are present throughout the life cycle (results not shown). We are currently developing antibodies and reporter gene constructs that will allow us to localize expression of the two subunits within the nematode nervous system. The study of these nematode inhibitory glutamate receptors promises to be of great utility in expanding our knowledge and understanding of the structure-function relationships of the whole superfamily of ligand-gated ion channels. Natural selection has produced a series of variations in these sequences which are far in excess of the most imaginative and far-reaching programme of site-directed mutagenesis, and these variations have a number of intriguing new pharmacological and physiological properties. If we understand them, we will also understand mammalian GABA and glycine receptors better, and the study of invertebrate receptors can be seen as a central part of our attempts to understand neurotransmission in all species.
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